Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Cancer Reports (Hoboken, N.J.)|February 7, 2023
Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomasSean S Mahase, Michelle Roytman, Diana Roth O'Brien, et al.
Cancer Discovery|April 8, 2020
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary GlioblastomasAllison R Pine, Stefano M Cirigliano, James G Nicholson, et al.
Human Gene Therapy|July 12, 2012
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for gliomaRichard A Morgan, Laura A Johnson, Jeremy L Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiformeJohn K Park, Tiffany Hodges, Leopold Arko, et al.
Neuro-Oncology Advances|August 4, 2021
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical centerPeter C Pan, David J Pisapia, Rohan Ramakrishna, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 9, 2008
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasJingxin Qiu, Lingbao Ai, Cheppail Ramachandran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Lead, genetic susceptibility, and risk of adult brain tumorsPreetha Rajaraman, Patricia A Stewart, Jonathan M Samet, et al.
Biorxiv : the Preprint Server for Biology|March 4, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Molecular Cell|March 27, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Cancer Reports (Hoboken, N.J.)|February 7, 2023
Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomasSean S Mahase, Michelle Roytman, Diana Roth O'Brien, et al.
Cancer Discovery|April 8, 2020
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary GlioblastomasAllison R Pine, Stefano M Cirigliano, James G Nicholson, et al.
Human Gene Therapy|July 12, 2012
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for gliomaRichard A Morgan, Laura A Johnson, Jeremy L Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiformeJohn K Park, Tiffany Hodges, Leopold Arko, et al.
Neuro-Oncology Advances|August 4, 2021
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical centerPeter C Pan, David J Pisapia, Rohan Ramakrishna, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 9, 2008
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasJingxin Qiu, Lingbao Ai, Cheppail Ramachandran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Lead, genetic susceptibility, and risk of adult brain tumorsPreetha Rajaraman, Patricia A Stewart, Jonathan M Samet, et al.
Biorxiv : the Preprint Server for Biology|March 4, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Molecular Cell|March 27, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Pageof 17